INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
76 hedge funds and large institutions have $30.8M invested in Infinity Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
62% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 26
Holders
76
Holding in Top 10
–
Calls
$482K
Puts
$111K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$1.49M | |
| 3 | +$1M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$386K |
| 5 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$157K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$903K | |
| 3 | -$267K | |
| 4 |
Morgan Stanley
New York
|
-$215K |
| 5 |
Goldman Sachs
New York
|
-$188K |